Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $73.05 Million |
|---|---|
| Enterprise Value | $72.01 Million |
| Earnings per Share | $-0.42 |
| Beta | -0.97 |
| Outstanding Shares | 18,127,103 |
| P/E Ratio | -5.25 |
|---|---|
| PEG | 37.62 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 83.83 |
| Enterprise Value to EBIT | -10.94 |
| Enterprise Value to Net Income | -12 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 1.54 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Harvard Apparatus Regenerative Technology Inc., a biotechnology firm currently conducting clinical trials, is dedicated to developing regenerative medical therapies. Its core mission involves addressing conditions affecting the gastroint...